INNOVATIVE PILOT PROGRAM FOR COVID-19 MONITORING IN WASTEWATER LAUNCHED AT OKLAHOMA CORRECTIONAL FACILITIES Program includes CDC, State of Oklahoma, Water Environment Federation, and Hach Alexandria, VA – A breakthrough method for testing wastewater for COVID-19 that provides rapid results is being piloted at correctional facilities in Oklahoma through funding from the U.S. Centers for Disease Control […]
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models Dublin, Ireland & Shizuoka, Japan: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Japan SLC, Inc., a biotechnology company providing animal models to the research community, today […]
SOUTH SAN FRANCISCO, Calif. & KAWASAKI, Japan — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline of antibody candidates. The collaborative research […]
SOUTH SAN FRANCISCO, Calif.— Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants first identified in India and spreading rapidly worldwide. “Just […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has […]
Alliance to expand the range of therapeutic and vaccine applications for the BioXp™ system SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Codex DNA will integrate […]
SAN DIEGO — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Codex DNA will integrate the mRNA capping technology into its suite of automated mRNA synthesis kits for the […]
Endress+Hauser BioSense to develop equipment and methods for fast molecular analyses Weil am Rhein Increased safety in food production and other process applications is the declared aim of the joint venture between Endress+Hauser and Hahn-Schickard. To this end, both partners have established Endress+Hauser BioSense GmbH based in Freiburg, Germany. Its aim is to enable rapid, […]
TOKYO — OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV). OriCiro has also received a ¥200 million […]
TOKYO — OriCiroGenomics is a pioneer in cell-free DNA synthesis and amplification for genome-scale large-scale genetic therapy and synthetic biology. Today, the company announced that Shigemasa (“Shige”) Sasaki was appointed Chief Operating Officer/Chief Technology Officer and Nasir Kato Bashiruddin, Ph.D. as Chief Technology Officer. While Mr. Sasaki will be responsible for all aspects of the […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
